Okusaka T - Search Results

1

Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study.

Chau I, Peck-Radosavljevic M, Borg C, Malfertheiner P, Seitz JF, Park JO, Ryoo BY, Yen CJ, Kudo M, Poon R, Pastorelli D, Blanc JF, Chung HC, Baron AD, Okusaka T, Bowman L, Cui ZL, Girvan AC, Abada PB, Yang L, Zhu AX. Chau I, et al. Among authors: okusaka t. Eur J Cancer. 2017 Aug;81:17-25. doi: 10.1016/j.ejca.2017.05.001. Epub 2017 Jun 4. Eur J Cancer. 2017. PMID: 28591675 Clinical Trial.

2

Intratumoral DNA heterogeneity of small hepatocellular carcinoma.

Okada S, Ishii H, Nose H, Okusaka T, Kyogoku A, Yoshimori M, Sakamoto M, Hirohashi S. Okada S, et al. Among authors: okusaka t. Cancer. 1995 Jan 15;75(2):444-50. doi: 10.1002/1097-0142(19950115)75:2<444::aid-cncr2820750206>3.0.co;2-p. Cancer. 1995. PMID: 7812914

3

Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection.

Ishii H, Okada S, Nose H, Okusaka T, Yoshimori M, Takayama T, Kosuge T, Yamasaki S, Sakamoto M, Hirohashi S. Ishii H, et al. Among authors: okusaka t. Cancer. 1996 May 1;77(9):1792-6. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1792::AID-CNCR6>3.0.CO;2-E. Cancer. 1996. PMID: 8646676

4

Clinical response to systemic combined chemotherapy with 5-fluorouracil and cisplatin (FP therapy) in patients with advanced pancreatic cancer.

Okusaka T, Okada S, Ishii H, Nose H, Nakasuka H, Nakayama H, Nagahama H. Okusaka T, et al. Jpn J Clin Oncol. 1996 Aug;26(4):215-20. doi: 10.1093/oxfordjournals.jjco.a023217. Jpn J Clin Oncol. 1996. PMID: 8765178 Clinical Trial.

5

Predictive factors for recurrence after percutaneous ethanol injection for solitary hepatocellular carcinoma.

Ishii H, Okada S, Nose H, Okusaka T, Nagahama H, Nakayama H, Nakasuka H, Yoshimori M. Ishii H, et al. Among authors: okusaka t. Hepatogastroenterology. 1996 Jul-Aug;43(10):938-43. Hepatogastroenterology. 1996. PMID: 8884317

6

Prognosis of hepatocellular carcinoma patients with extrahepatic metastases.

Okusaka T, Okada S, Ishii H, Nose H, Nagahama H, Nakasuka H, Ikeda K, Yoshimori M. Okusaka T, et al. Hepatogastroenterology. 1997 Jan-Feb;44(13):251-7. Hepatogastroenterology. 1997. PMID: 9058154

7

Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma.

Ishii H, Okada S, Tokuuye K, Nose H, Okusaka T, Yoshimori M, Nagahama H, Sumi M, Kagami Y, Ikeda H. Ishii H, et al. Among authors: okusaka t. Cancer. 1997 Apr 15;79(8):1516-20. Cancer. 1997. PMID: 9118032 Clinical Trial.

8

Predictive factors for tumor response to systemic chemotherapy in patients with hepatocellular carcinoma.

Nagahama H, Okada S, Okusaka T, Ishii H, Ikeda M, Nakasuka H, Yoshimori M. Nagahama H, et al. Among authors: okusaka t. Jpn J Clin Oncol. 1997 Oct;27(5):321-4. doi: 10.1093/jjco/27.5.321. Jpn J Clin Oncol. 1997. PMID: 9390209

9

Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection.

Ishii H, Okada S, Okusaka T, Yoshimori M, Nakasuka H, Shimada K, Yamasaki S, Nakanishi Y, Sakamoto M. Ishii H, et al. Among authors: okusaka t. Cancer. 1998 May 1;82(9):1638-42. Cancer. 1998. PMID: 9576282 Clinical Trial.

10

Past exposure to hepatitis B virus as a risk factor for hepatocellular carcinoma in patients with chronic liver disease.

Okada S, Sato T, Okusaka T, Ishii H, Ikeda M, Nakasuka H, Kosakamoto H, Yoshimori M, Wakabayashi K. Okada S, et al. Among authors: okusaka t. Br J Cancer. 1998 Jun;77(11):2028-31. doi: 10.1038/bjc.1998.337. Br J Cancer. 1998. PMID: 9667687 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

525 results

Search Page